| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of translation | 3.77e-05 | 494 | 17 | 5 | GO:0006417 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 2.19e-04 | 1153 | 17 | 6 | GO:0010608 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 2.43e-04 | 151 | 17 | 3 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 2.56e-04 | 29 | 17 | 2 | GO:0031954 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via nonhomologous end joining | 3.13e-04 | 32 | 17 | 2 | GO:2001032 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 3.64e-04 | 432 | 17 | 4 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.00e-04 | 443 | 17 | 4 | GO:1903311 | |
| GeneOntologyBiologicalProcess | translation | 4.16e-04 | 824 | 17 | 5 | GO:0006412 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 4.77e-04 | 464 | 17 | 4 | GO:0141188 | |
| GeneOntologyBiologicalProcess | RNA splicing | 6.41e-04 | 502 | 17 | 4 | GO:0008380 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 6.48e-04 | 46 | 17 | 2 | GO:0031952 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 6.80e-04 | 917 | 17 | 5 | GO:0016071 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 8.29e-04 | 230 | 17 | 3 | GO:0017148 | |
| GeneOntologyBiologicalProcess | mRNA processing | 9.09e-04 | 551 | 17 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.17e-03 | 259 | 17 | 3 | GO:1903313 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.21e-03 | 63 | 17 | 2 | GO:0033120 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 5.59e-05 | 269 | 17 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 6.09e-05 | 96 | 17 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 7.19e-05 | 287 | 17 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 2.46e-04 | 1194 | 17 | 6 | GO:1990904 | |
| GeneOntologyCellularComponent | spliceosomal complex | 6.56e-04 | 215 | 17 | 3 | GO:0005681 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 2.77e-03 | 97 | 17 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | site of double-strand break | 3.00e-03 | 101 | 17 | 2 | GO:0035861 | |
| GeneOntologyCellularComponent | P-body | 3.06e-03 | 102 | 17 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.91e-03 | 1377 | 17 | 5 | GO:0140513 | |
| GeneOntologyCellularComponent | site of DNA damage | 5.44e-03 | 137 | 17 | 2 | GO:0090734 | |
| Domain | FFD_box | 7.80e-07 | 2 | 17 | 2 | IPR025761 | |
| Domain | FFD | 7.80e-07 | 2 | 17 | 2 | PS51513 | |
| Domain | TFG_box | 7.80e-07 | 2 | 17 | 2 | IPR025768 | |
| Domain | TFG | 7.80e-07 | 2 | 17 | 2 | PS51536 | |
| Domain | LSM14 | 2.34e-06 | 3 | 17 | 2 | SM01271 | |
| Domain | DFDF | 2.34e-06 | 3 | 17 | 2 | IPR025762 | |
| Domain | LSM14 | 2.34e-06 | 3 | 17 | 2 | PF12701 | |
| Domain | DFDF | 2.34e-06 | 3 | 17 | 2 | PS51512 | |
| Domain | FDF | 2.34e-06 | 3 | 17 | 2 | SM01199 | |
| Domain | FDF | 2.34e-06 | 3 | 17 | 2 | PF09532 | |
| Domain | Lsm14_N | 2.34e-06 | 3 | 17 | 2 | IPR025609 | |
| Domain | FDF_dom | 2.34e-06 | 3 | 17 | 2 | IPR019050 | |
| Domain | HnRNP_R/Q_splicing_fac | 7.79e-06 | 5 | 17 | 2 | IPR006535 | |
| Domain | LSM_dom | 1.78e-04 | 22 | 17 | 2 | IPR010920 | |
| Domain | RRM_1 | 8.25e-04 | 208 | 17 | 3 | PF00076 | |
| Domain | RRM | 9.33e-04 | 217 | 17 | 3 | SM00360 | |
| Domain | RRM_dom | 1.06e-03 | 227 | 17 | 3 | IPR000504 | |
| Domain | RRM | 1.10e-03 | 230 | 17 | 3 | PS50102 | |
| Domain | - | 1.31e-03 | 244 | 17 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.54e-03 | 258 | 17 | 3 | IPR012677 | |
| Domain | WD40 | 2.27e-02 | 259 | 17 | 2 | PF00400 | |
| Domain | WD40 | 2.42e-02 | 268 | 17 | 2 | SM00320 | |
| Domain | WD40_repeat | 2.49e-02 | 272 | 17 | 2 | IPR001680 | |
| Domain | WD_REPEATS_1 | 2.59e-02 | 278 | 17 | 2 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.61e-02 | 279 | 17 | 2 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.61e-02 | 279 | 17 | 2 | PS50294 | |
| Domain | WD40_repeat_dom | 2.93e-02 | 297 | 17 | 2 | IPR017986 | |
| Domain | - | 3.61e-02 | 333 | 17 | 2 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.65e-02 | 335 | 17 | 2 | IPR015943 | |
| Pubmed | 9.93e-10 | 551 | 22 | 8 | 34728620 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.06e-08 | 258 | 22 | 6 | 37794589 | |
| Pubmed | 6.48e-08 | 170 | 22 | 5 | 15057823 | ||
| Pubmed | 7.00e-08 | 1371 | 22 | 9 | 36244648 | ||
| Pubmed | 3.01e-07 | 1153 | 22 | 8 | 29845934 | ||
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 1.15e-06 | 3 | 22 | 2 | 30755280 | |
| Pubmed | SMN interacts with a novel family of hnRNP and spliceosomal proteins. | 2.29e-06 | 4 | 22 | 2 | 11574476 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 11773003 | ||
| Pubmed | Novel Sm-like proteins with long C-terminal tails and associated methyltransferases. | 3.82e-06 | 5 | 22 | 2 | 15225602 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 4.47e-06 | 724 | 22 | 6 | 36232890 | |
| Pubmed | Functional association of human Ki-1/57 with pre-mRNA splicing events. | 5.72e-06 | 6 | 22 | 2 | 19523114 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 31422817 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 8.32e-06 | 807 | 22 | 6 | 22681889 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 19808671 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 12183049 | ||
| Pubmed | 1.93e-05 | 1429 | 22 | 7 | 35140242 | ||
| Pubmed | 2.01e-05 | 260 | 22 | 4 | 36199071 | ||
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 10734137 | ||
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 2.09e-05 | 11 | 22 | 2 | 37142680 | |
| Pubmed | 2.17e-05 | 86 | 22 | 3 | 26885983 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 2.29e-05 | 269 | 22 | 4 | 30442662 | |
| Pubmed | 2.37e-05 | 971 | 22 | 6 | 33306668 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 16236758 | ||
| Pubmed | 3.42e-05 | 298 | 22 | 4 | 30737378 | ||
| Pubmed | 3.49e-05 | 615 | 22 | 5 | 31048545 | ||
| Pubmed | Ki-1/57 interacts with PRMT1 and is a substrate for arginine methylation. | 3.99e-05 | 15 | 22 | 2 | 16879614 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 4.25e-05 | 315 | 22 | 4 | 26777405 | |
| Pubmed | 4.71e-05 | 655 | 22 | 5 | 35819319 | ||
| Pubmed | 4.84e-05 | 1103 | 22 | 6 | 34189442 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 5.03e-05 | 329 | 22 | 4 | 34316702 | |
| Pubmed | 5.16e-05 | 17 | 22 | 2 | 12388589 | ||
| Pubmed | 6.03e-05 | 121 | 22 | 3 | 34029587 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 6.25e-05 | 1155 | 22 | 6 | 20360068 | |
| Pubmed | 6.48e-05 | 124 | 22 | 3 | 23000965 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 6.63e-05 | 704 | 22 | 5 | 32994395 | |
| Pubmed | 7.04e-05 | 713 | 22 | 5 | 29802200 | ||
| Pubmed | 7.63e-05 | 131 | 22 | 3 | 28031328 | ||
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 8.16e-05 | 134 | 22 | 3 | 28695742 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 9.99e-05 | 1257 | 22 | 6 | 36526897 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 1.07e-04 | 400 | 22 | 4 | 35013556 | |
| Pubmed | 1.35e-04 | 159 | 22 | 3 | 22751105 | ||
| Pubmed | 1.39e-04 | 1335 | 22 | 6 | 29229926 | ||
| Pubmed | 1.43e-04 | 162 | 22 | 3 | 21890473 | ||
| Pubmed | 1.58e-04 | 847 | 22 | 5 | 35850772 | ||
| Pubmed | Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. | 1.95e-04 | 180 | 22 | 3 | 21139048 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.07e-04 | 475 | 22 | 4 | 31040226 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.10e-04 | 477 | 22 | 4 | 31300519 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 2.15e-04 | 480 | 22 | 4 | 25437307 | |
| Pubmed | 2.38e-04 | 36 | 22 | 2 | 17289661 | ||
| Pubmed | An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry. | 3.40e-04 | 43 | 22 | 2 | 30975701 | |
| Pubmed | 3.53e-04 | 547 | 22 | 4 | 37267103 | ||
| Pubmed | Identification of DeltaNp63alpha protein interactions by mass spectrometry. | 4.23e-04 | 48 | 22 | 2 | 20085233 | |
| Pubmed | 4.82e-04 | 245 | 22 | 3 | 35652658 | ||
| Pubmed | 4.82e-04 | 245 | 22 | 3 | 21182205 | ||
| Pubmed | Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. | 5.97e-04 | 57 | 22 | 2 | 18781797 | |
| Interaction | ZNF683 interactions | 1.85e-13 | 10 | 21 | 5 | int:ZNF683 | |
| Interaction | CELF4 interactions | 3.38e-13 | 11 | 21 | 5 | int:CELF4 | |
| Interaction | BEND2 interactions | 5.79e-13 | 12 | 21 | 5 | int:BEND2 | |
| Interaction | PTTG2 interactions | 1.46e-12 | 14 | 21 | 5 | int:PTTG2 | |
| Interaction | MBNL3 interactions | 3.19e-12 | 16 | 21 | 5 | int:MBNL3 | |
| Interaction | KRTAP19-1 interactions | 6.10e-12 | 47 | 21 | 6 | int:KRTAP19-1 | |
| Interaction | EIF4ENIF1 interactions | LSM14B PRR20A PRR20E LSM14A PRR20C PRR20D PRRC2B PRR20B SYNCRIP | 8.00e-12 | 300 | 21 | 9 | int:EIF4ENIF1 |
| Interaction | OXER1 interactions | 9.02e-12 | 50 | 21 | 6 | int:OXER1 | |
| Interaction | PRR34 interactions | 1.48e-11 | 21 | 21 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 1.48e-11 | 21 | 21 | 5 | int:TPRX1 | |
| Interaction | CABP2 interactions | 3.13e-11 | 61 | 21 | 6 | int:CABP2 | |
| Interaction | C10orf55 interactions | 4.64e-11 | 65 | 21 | 6 | int:C10orf55 | |
| Interaction | C3orf36 interactions | 4.77e-11 | 26 | 21 | 5 | int:C3orf36 | |
| Interaction | DAZL interactions | 9.22e-11 | 145 | 21 | 7 | int:DAZL | |
| Interaction | ZNF385C interactions | 1.71e-10 | 33 | 21 | 5 | int:ZNF385C | |
| Interaction | HLX interactions | 3.14e-10 | 37 | 21 | 5 | int:HLX | |
| Interaction | ZCCHC14 interactions | 3.14e-10 | 37 | 21 | 5 | int:ZCCHC14 | |
| Interaction | DAZAP2 interactions | 5.31e-10 | 186 | 21 | 7 | int:DAZAP2 | |
| Interaction | TBX6 interactions | 5.38e-10 | 41 | 21 | 5 | int:TBX6 | |
| Interaction | FAM222B interactions | 6.10e-10 | 42 | 21 | 5 | int:FAM222B | |
| Interaction | SAMD11 interactions | 6.90e-10 | 43 | 21 | 5 | int:SAMD11 | |
| Interaction | BICRAL interactions | 6.90e-10 | 43 | 21 | 5 | int:BICRAL | |
| Interaction | C1orf94 interactions | 7.84e-10 | 103 | 21 | 6 | int:C1orf94 | |
| Interaction | RBM42 interactions | 8.22e-10 | 331 | 21 | 8 | int:RBM42 | |
| Interaction | RHOXF2 interactions | 8.32e-10 | 104 | 21 | 6 | int:RHOXF2 | |
| Interaction | VENTX interactions | 8.32e-10 | 104 | 21 | 6 | int:VENTX | |
| Interaction | SP4 interactions | 9.80e-10 | 46 | 21 | 5 | int:SP4 | |
| Interaction | FOXH1 interactions | 1.11e-09 | 109 | 21 | 6 | int:FOXH1 | |
| Interaction | RIPPLY1 interactions | 2.47e-09 | 55 | 21 | 5 | int:RIPPLY1 | |
| Interaction | ZBTB32 interactions | 3.25e-09 | 58 | 21 | 5 | int:ZBTB32 | |
| Interaction | FAM9A interactions | 3.55e-09 | 59 | 21 | 5 | int:FAM9A | |
| Interaction | TFG interactions | 5.18e-09 | 258 | 21 | 7 | int:TFG | |
| Interaction | VPS37C interactions | 5.25e-09 | 141 | 21 | 6 | int:VPS37C | |
| Interaction | LSM14A interactions | 5.47e-09 | 260 | 21 | 7 | int:LSM14A | |
| Interaction | FAM168A interactions | 5.47e-09 | 142 | 21 | 6 | int:FAM168A | |
| Interaction | CPEB1 interactions | 6.47e-09 | 146 | 21 | 6 | int:CPEB1 | |
| Interaction | SMAP1 interactions | 6.81e-09 | 67 | 21 | 5 | int:SMAP1 | |
| Interaction | POU6F2 interactions | 7.02e-09 | 148 | 21 | 6 | int:POU6F2 | |
| Interaction | SNRPC interactions | 7.69e-09 | 440 | 21 | 8 | int:SNRPC | |
| Interaction | TBX3 interactions | 7.92e-09 | 69 | 21 | 5 | int:TBX3 | |
| Interaction | CAPRIN1 interactions | 9.32e-09 | 451 | 21 | 8 | int:CAPRIN1 | |
| Interaction | ESRP1 interactions | 1.38e-08 | 77 | 21 | 5 | int:ESRP1 | |
| Interaction | RBPMS2 interactions | 2.03e-08 | 83 | 21 | 5 | int:RBPMS2 | |
| Interaction | PRR35 interactions | 2.03e-08 | 83 | 21 | 5 | int:PRR35 | |
| Interaction | DMRT3 interactions | 2.57e-08 | 87 | 21 | 5 | int:DMRT3 | |
| Interaction | PRR20B interactions | 3.05e-08 | 90 | 21 | 5 | int:PRR20B | |
| Interaction | PRR20C interactions | 3.05e-08 | 90 | 21 | 5 | int:PRR20C | |
| Interaction | PRR20D interactions | 3.05e-08 | 90 | 21 | 5 | int:PRR20D | |
| Interaction | RBPMS interactions | 3.47e-08 | 340 | 21 | 7 | int:RBPMS | |
| Interaction | RBM23 interactions | 3.80e-08 | 94 | 21 | 5 | int:RBM23 | |
| Interaction | ZC3H10 interactions | 4.25e-08 | 200 | 21 | 6 | int:ZC3H10 | |
| Interaction | KRTAP19-5 interactions | 4.94e-08 | 99 | 21 | 5 | int:KRTAP19-5 | |
| Interaction | PRR20E interactions | 5.46e-08 | 101 | 21 | 5 | int:PRR20E | |
| Interaction | TRIM35 interactions | 6.03e-08 | 103 | 21 | 5 | int:TRIM35 | |
| Interaction | GTF2A1 interactions | 6.33e-08 | 104 | 21 | 5 | int:GTF2A1 | |
| Interaction | VEZF1 interactions | 6.64e-08 | 105 | 21 | 5 | int:VEZF1 | |
| Interaction | ANKHD1 interactions | 6.71e-08 | 216 | 21 | 6 | int:ANKHD1 | |
| Interaction | GLIS2 interactions | 6.97e-08 | 106 | 21 | 5 | int:GLIS2 | |
| Interaction | SH3RF1 interactions | 7.65e-08 | 108 | 21 | 5 | int:SH3RF1 | |
| Interaction | PRR20A interactions | 8.01e-08 | 109 | 21 | 5 | int:PRR20A | |
| Interaction | NOTCH3 interactions | 9.60e-08 | 113 | 21 | 5 | int:NOTCH3 | |
| Interaction | BHLHE40 interactions | 1.24e-07 | 119 | 21 | 5 | int:BHLHE40 | |
| Interaction | THAP1 interactions | 1.24e-07 | 119 | 21 | 5 | int:THAP1 | |
| Interaction | FBL interactions | 1.38e-07 | 639 | 21 | 8 | int:FBL | |
| Interaction | HYPK interactions | 1.59e-07 | 125 | 21 | 5 | int:HYPK | |
| Interaction | PRMT1 interactions | 1.61e-07 | 929 | 21 | 9 | int:PRMT1 | |
| Interaction | PITX1 interactions | 1.72e-07 | 127 | 21 | 5 | int:PITX1 | |
| Interaction | CCNK interactions | 2.09e-07 | 132 | 21 | 5 | int:CCNK | |
| Interaction | YPEL3 interactions | 2.17e-07 | 133 | 21 | 5 | int:YPEL3 | |
| Interaction | BANP interactions | 2.91e-07 | 277 | 21 | 6 | int:BANP | |
| Interaction | ARID5A interactions | 3.57e-07 | 147 | 21 | 5 | int:ARID5A | |
| Interaction | TLX3 interactions | 3.89e-07 | 291 | 21 | 6 | int:TLX3 | |
| Interaction | MAGED1 interactions | 4.22e-07 | 295 | 21 | 6 | int:MAGED1 | |
| Interaction | RPS20 interactions | 5.67e-07 | 513 | 21 | 7 | int:RPS20 | |
| Interaction | PATZ1 interactions | 5.96e-07 | 163 | 21 | 5 | int:PATZ1 | |
| Interaction | SNRPB interactions | 5.98e-07 | 517 | 21 | 7 | int:SNRPB | |
| Interaction | PHF1 interactions | 7.78e-07 | 172 | 21 | 5 | int:PHF1 | |
| Interaction | TIAL1 interactions | 7.78e-07 | 172 | 21 | 5 | int:TIAL1 | |
| Interaction | POU2F1 interactions | 8.48e-07 | 175 | 21 | 5 | int:POU2F1 | |
| Interaction | NFYC interactions | 8.97e-07 | 177 | 21 | 5 | int:NFYC | |
| Interaction | HIVEP1 interactions | 1.15e-06 | 186 | 21 | 5 | int:HIVEP1 | |
| Interaction | TOLLIP interactions | 1.31e-06 | 358 | 21 | 6 | int:TOLLIP | |
| Interaction | VAC14 interactions | 1.68e-06 | 201 | 21 | 5 | int:VAC14 | |
| Interaction | RBMS1 interactions | 1.94e-06 | 207 | 21 | 5 | int:RBMS1 | |
| Interaction | MOV10 interactions | 2.67e-06 | 1297 | 21 | 9 | int:MOV10 | |
| Interaction | SIAH1 interactions | 2.79e-06 | 223 | 21 | 5 | int:SIAH1 | |
| Interaction | FXR2 interactions | 3.77e-06 | 430 | 21 | 6 | int:FXR2 | |
| Interaction | NTAQ1 interactions | 3.82e-06 | 431 | 21 | 6 | int:NTAQ1 | |
| Interaction | YTHDF3 interactions | 4.51e-06 | 246 | 21 | 5 | int:YTHDF3 | |
| Interaction | LASP1 interactions | 4.60e-06 | 247 | 21 | 5 | int:LASP1 | |
| Interaction | SRPK2 interactions | 5.27e-06 | 717 | 21 | 7 | int:SRPK2 | |
| Interaction | ATXN1 interactions | 5.42e-06 | 1039 | 21 | 8 | int:ATXN1 | |
| Interaction | NCK2 interactions | 6.13e-06 | 262 | 21 | 5 | int:NCK2 | |
| Interaction | POGZ interactions | 6.48e-06 | 265 | 21 | 5 | int:POGZ | |
| Interaction | DVL3 interactions | 8.47e-06 | 280 | 21 | 5 | int:DVL3 | |
| Interaction | LARP7 interactions | 9.00e-06 | 1113 | 21 | 8 | int:LARP7 | |
| Interaction | TCF7L2 interactions | 9.23e-06 | 285 | 21 | 5 | int:TCF7L2 | |
| Interaction | ABI2 interactions | 9.39e-06 | 286 | 21 | 5 | int:ABI2 | |
| Interaction | CELF1 interactions | 9.71e-06 | 288 | 21 | 5 | int:CELF1 | |
| Interaction | YTHDF2 interactions | 1.43e-05 | 312 | 21 | 5 | int:YTHDF2 | |
| Cytoband | 13q21.1 | 1.99e-14 | 13 | 22 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 2.51e-09 | 117 | 22 | 5 | chr13q21 | |
| Cytoband | 11q21 | 2.05e-04 | 44 | 22 | 2 | 11q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q21 | 4.21e-04 | 63 | 22 | 2 | chr11q21 | |
| GeneFamily | RNA binding motif containing | 1.82e-04 | 213 | 10 | 3 | 725 | |
| GeneFamily | WD repeat domain containing | 8.72e-03 | 262 | 10 | 2 | 362 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 5.86e-05 | 341 | 17 | 4 | M2879 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 1.17e-04 | 408 | 17 | 4 | M11891 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 1.25e-04 | 415 | 17 | 4 | MM1028 | |
| Computational | Neighborhood of MAX | 4.36e-04 | 31 | 11 | 2 | GCM_MAX | |
| Computational | Neighborhood of MYST2 | 6.04e-04 | 172 | 11 | 3 | GCM_MYST2 | |
| Computational | Neighborhood of DENR | 1.18e-03 | 51 | 11 | 2 | GNF2_DENR | |
| Computational | Neighborhood of SMC1L1 | 1.74e-03 | 62 | 11 | 2 | MORF_SMC1L1 | |
| Disease | obsolete aging, cognition | 3.26e-13 | 15 | 21 | 5 | EFO_0003925, GO_0007568 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 9.49e-10 | 66 | 21 | 5 | EFO_0007708 | |
| Disease | mosaic loss of chromosome Y measurement | 2.54e-09 | 80 | 21 | 5 | EFO_0007783 | |
| Disease | Tinnitus, wellbeing measurement | 6.41e-09 | 96 | 21 | 5 | EFO_0007869, HP_0000360 | |
| Disease | telomere length | 2.30e-06 | 313 | 21 | 5 | EFO_0004505 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSNRGRGRSRPRGGT | 361 | Q58WW2 | |
| QQPGSRNRGRGQGRG | 51 | O60565 | |
| RNRGRGQGRGTAMPG | 56 | O60565 | |
| GFRGGRGNGTTRRNP | 361 | Q9BX40 | |
| RGGRGRIRRAENYGP | 376 | Q5JVS0 | |
| RGARGGAQQQRGRGV | 536 | O60506 | |
| GAQQQRGRGVRGARG | 541 | O60506 | |
| RGGPAQQQRGRGSRG | 546 | O43390 | |
| RGRGQGQGRGCSRGR | 441 | B2RXH2 | |
| RPNRGRGGYRGRGGL | 401 | Q8ND56 | |
| RGRGRRAGPRGDAGQ | 86 | P86480 | |
| RGRGRRAGPRGDAGQ | 86 | P86496 | |
| RGRGRRAGPRGDAGQ | 86 | P86481 | |
| SRGGRRAPGRGQQGL | 826 | Q99575 | |
| RNYGQLGGGPGRRRR | 736 | Q12770 | |
| GGNIRGSFRGRGRGR | 141 | Q659C4 | |
| GRGRGRGRGNPRLNF | 156 | Q659C4 | |
| RGRGRRAGPRGDAGQ | 86 | P86479 | |
| RGRGRRAGPRGDAGQ | 86 | P86478 | |
| GRGRGRRGGRGQNSA | 571 | P49959 | |
| LRGRGFSRNPRGRGL | 146 | Q7Z7L8 | |
| NRKGRGGNRGREFRG | 136 | Q5T6F2 | |
| RVPRGGGRQGGRFER | 1046 | Q8N7X1 | |
| QAFGVRGQARGRGRG | 1056 | Q5JSZ5 | |
| GGRSRFSPQGGQRGR | 51 | O75360 |